Codon 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-2.42MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

co.don AG, a biopharmaceutical company, develops, produces, and markets biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three-dimensional cartilage cell transplant product that is used to treat cartilage defects in adult knee joints and adolescents; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, and shoulder and elbow. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Show More
CEO
Employees
134
Country
Germany
ISIN
DE000A1K0227
WKN
000A3E5C0

Listings

0 Comments

Share your thoughts

FAQs

What is Codon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Codon stocks are traded under the ticker CNWK.MU.
What is Codon revenue for the last year?▼
Codon revenue for the last year amounts to 0 EUR.
What is Codon net income for the last year?▼
CNWK.MU net income for the last year is -2.42M EUR.
How many employees does Codon have?▼
As of November 2, 2026, the company has 134 employees.
In which sector is Codon located?▼
Codon operates in the Energy sector.
When did Codon complete a stock split?▼
Codon has not had any recent stock splits.